{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:34:59Z","timestamp":1791923699843,"version":"4.3.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["22\/RP\/10091"],"award-info":[{"award-number":["22\/RP\/10091"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several transitions, or new patterns and dynamics in the contributors and health outcomes, have altered the character and burden of the multi-decade, worldwide growth in prevalence of type 2 diabetes (T2DM). These changes have led to different needs for prevention and care. These dynamics have been driven by diverse demographic, socio-economic, behavioural, and health system response factors. In this Perspective, we describe these transitions and how their attributes have set the stage for multimorbidity, or multiple long-term conditions (MLTCs), to be the next major challenge in the diabetes epidemic. We also describe how the timing and character of these stages differ in high-, middle-, and low-income countries. These challenges call for innovation and a stronger focus on MLTCs across the spectrum of cause, effectiveness, and implementation studies to guide prevention and treatment priorities.<\/jats:p>","DOI":"10.1038\/s43856-025-00742-9","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:25:24Z","timestamp":1739535924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Multiple long-term conditions as the next transition in the global diabetes epidemic"],"prefix":"10.1038","volume":"5","author":[{"given":"Edward W.","family":"Gregg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Sophiea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pearson-Stuttard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9756-4061","authenticated-orcid":false,"given":"Jonathan","family":"Valabhji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"742_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/j.1468-0009.2005.00398.x","volume":"83","author":"AR Omran","year":"2005","unstructured":"Omran, A. R. The epidemiologic transition: a theory of the epidemiology of population change. 1971. Milbank Q 83, 731\u2013757 (2005).","journal-title":"Milbank Q"},{"key":"742_CR2","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s10654-021-00719-7","volume":"36","author":"JP Mackenbach","year":"2021","unstructured":"Mackenbach, J. P. The rise and fall of diseases: reflections on the history of population health in Europe since ca. 1700. Eur. J. Epidemiol. 36, 1199\u20131205 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"742_CR3","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1056\/NEJMsa053935","volume":"356","author":"ES Ford","year":"2007","unstructured":"Ford, E. S. et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356, 2388\u20132398 (2007).","journal-title":"N. Engl. J. Med."},{"key":"742_CR4","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1001\/jama.2014.11494","volume":"312","author":"LS Geiss","year":"2014","unstructured":"Geiss, L. S. et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. Jama 312, 1218\u20131226 (2014).","journal-title":"Jama"},{"key":"742_CR5","unstructured":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387, 1513\u20131530 (2016)."},{"key":"742_CR6","doi-asserted-by":"publisher","first-page":"e000657","DOI":"10.1136\/bmjdrc-2019-000657","volume":"7","author":"SR Benoit","year":"2019","unstructured":"Benoit, S. R., Hora, I., Albright, A. L. & Gregg, E. W. New directions in incidence and prevalence of diagnosed diabetes in the USA. BMJ Open Diabetes Res. Care 7, e000657 (2019).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"742_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S2213-8587(20)30402-2","volume":"9","author":"DJ Magliano","year":"2021","unstructured":"Magliano, D. J. et al. Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings. Lancet Diabetes Endocrinol. 9, 203\u2013211 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR8","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet 404, 2077\u20132093 (2024)."},{"key":"742_CR9","first-page":"22","volume":"17","author":"F Vinicor","year":"1994","unstructured":"Vinicor, F. Is diabetes a public-health disorder? Diabetes Care 17, 22\u201327 (1994).","journal-title":"Diabetes Care"},{"key":"742_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","volume":"2","author":"PZ Zimmet","year":"2014","unstructured":"Zimmet, P. Z., Magliano, D. J., Herman, W. H. & Shaw, J. E. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2, 56\u201364 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1067\/mpd.2000.105141","volume":"136","author":"A Fagot-Campagna","year":"2000","unstructured":"Fagot-Campagna, A. et al. Type 2 diabetes among North adolescents: an epidemiologic health perspective. J. Pediatrics 136, 664\u2013672 (2000).","journal-title":"J. Pediatrics"},{"key":"742_CR12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","volume":"4","author":"EW Gregg","year":"2016","unstructured":"Gregg, E. W., Sattar, N. & Ali, M. K. The changing face of diabetes complications. Lancet Diabetes Endocrinol. 4, 537\u2013547 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF00745137","volume":"13","author":"P Zimmet","year":"1977","unstructured":"Zimmet, P., Taft, P., Guinea, A., Guthrie, W. & Thoma, K. The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia 13, 111\u2013115 (1977).","journal-title":"Diabetologia"},{"key":"742_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(71)92303-8","volume":"2","author":"PH Bennett","year":"1971","unstructured":"Bennett, P. H., Burch, T. A. & Miller, M. Diabetes mellitus in American (Pima) Indians. Lancet 2, 125\u2013128 (1971).","journal-title":"Lancet"},{"key":"742_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2337\/diacare.2.2.63","volume":"2","author":"KM West","year":"1979","unstructured":"West, K. M. Epidemiology of diabetes and its macrovascular complications. Diabetes Care 2, 63\u201364 (1979).","journal-title":"Diabetes Care"},{"key":"742_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1079\/PHN19980004","volume":"1","author":"BM Popkin","year":"1998","unstructured":"Popkin, B. M. The nutrition transition and its health implications in lower-income countries. Public Health Nutr. 1, 5\u201321 (1998).","journal-title":"Public Health Nutr."},{"key":"742_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","volume":"7","author":"LM Jaacks","year":"2019","unstructured":"Jaacks, L. M. et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol. 7, 231\u2013240 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR18","unstructured":"Trends in the prevalence and incidence of self-reported diabetes mellitus\u2014United States, 1980-1994. MMWR Morb. Mortal Wkly. Rep. 46, 1014\u20131018 (1997)."},{"key":"742_CR19","first-page":"1","volume":"42","author":"LS Geiss","year":"1993","unstructured":"Geiss, L. S. et al. Surveillance for diabetes mellitus\u2013United States, 1980-1989. MMWR CDC Surveill. Summ. 42, 1\u201320 (1993).","journal-title":"MMWR CDC Surveill. Summ."},{"key":"742_CR20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2337\/diacare.15.8.960","volume":"15","author":"SF Wetterhall","year":"1992","unstructured":"Wetterhall, S. F. et al. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care 15, 960\u2013967 (1992).","journal-title":"Diabetes Care"},{"key":"742_CR21","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","volume":"370","author":"EW Gregg","year":"2014","unstructured":"Gregg, E. W. et al. Changes in diabetes-related complications in the United States, 1990-2010. N. Engl. J. Med. 370, 1514\u20131523 (2014).","journal-title":"N. Engl. J. Med."},{"key":"742_CR22","doi-asserted-by":"publisher","first-page":"C39","DOI":"10.2337\/diacare.21.3.C39","volume":"21","author":"R Klein","year":"1998","unstructured":"Klein, R. & Klein, B. E. Relation of glycemic control to diabetic complications and health outcomes. Diabetes Care 21, C39\u2013C43 (1998).","journal-title":"Diabetes Care"},{"key":"742_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJM199807233390404","volume":"339","author":"SM Haffner","year":"1998","unstructured":"Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K. & Laakso, M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339, 229\u2013234 (1998).","journal-title":"N. Engl. J. Med."},{"key":"742_CR24","doi-asserted-by":"publisher","first-page":"e0268805","DOI":"10.1371\/journal.pone.0268805","volume":"17","author":"AK Koyama","year":"2022","unstructured":"Koyama, A. K. et al. Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997-2018. PLoS One 17, e0268805 (2022).","journal-title":"PLoS One"},{"key":"742_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/BF00274774","volume":"31","author":"RG Nelson","year":"1988","unstructured":"Nelson, R. G. et al. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 31, 730\u2013736 (1988).","journal-title":"Diabetologia"},{"key":"742_CR26","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1161\/01.STR.28.6.1142","volume":"28","author":"CJ Currie","year":"1997","unstructured":"Currie, C. J., Morgan, C. L., Gill, L., Stott, N. C. & Peters, J. R. Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations. Stroke 28, 1142\u20131146 (1997).","journal-title":"Stroke"},{"key":"742_CR27","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2337\/diacare.21.9.1432","volume":"21","author":"GL Beckles","year":"1998","unstructured":"Beckles, G. L. et al. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 21, 1432\u20131438 (1998).","journal-title":"Diabetes Care"},{"key":"742_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.7326\/0003-4819-144-7-200604040-00005","volume":"144","author":"JB Saaddine","year":"2006","unstructured":"Saaddine, J. B. et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann. Intern. Med. 144, 465\u2013474 (2006).","journal-title":"Ann. Intern. Med."},{"key":"742_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7326\/0003-4819-136-8-200204160-00005","volume":"136","author":"JB Saaddine","year":"2002","unstructured":"Saaddine, J. B. et al. A diabetes report card for the United States: quality of care in the 1990s. Ann. Intern. Med. 136, 565\u2013574 (2002).","journal-title":"Ann. Intern. Med."},{"key":"742_CR30","doi-asserted-by":"crossref","unstructured":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317, 703\u2013713 (1998).","DOI":"10.1136\/bmj.317.7160.703"},{"key":"742_CR31","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837\u2013853 (1998).","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"742_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede, P. et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348, 383\u2013393 (2003).","journal-title":"N. Engl. J. Med."},{"key":"742_CR33","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2337\/diacare.24.10.1815","volume":"24","author":"BB Fleming","year":"2001","unstructured":"Fleming, B. B. et al. The diabetes quality improvement project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care 24, 1815\u20131820 (2001).","journal-title":"Diabetes Care"},{"key":"742_CR34","doi-asserted-by":"crossref","unstructured":"Burrows, N. R., Li, Y., Geiss, L. S. & Gregg, E. W. Declining rates of hospitalization for selected cardiovascular disease conditions among adults aged \u226535 years with diagnosed diabetes, US, 1998-2014. Diabetes Care 2018;41:293\u2013302 Response. Diabetes Care 41, E59-E59 (2018).","DOI":"10.2337\/dci17-0062"},{"key":"742_CR35","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","volume":"368","author":"MK Ali","year":"2013","unstructured":"Ali, M. K. et al. Achievement of goals in U.S. diabetes care, 1999-2010. N. Engl. J. Med. 368, 1613\u20131624 (2013).","journal-title":"N. Engl. J. Med."},{"key":"742_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"Harding, J. L., Pavkov, M. E., Magliano, D. J., Shaw, J. E. & Gregg, E. W. Global trends in diabetes complications: a review of current evidence. Diabetologia 62, 3\u201316 (2019).","journal-title":"Diabetologia"},{"key":"742_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2213-8587(21)00288-6","volume":"10","author":"J Pearson-Stuttard","year":"2022","unstructured":"Pearson-Stuttard, J. et al. Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol. 10, 46\u201357 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7326\/M14-0019","volume":"161","author":"MK Ali","year":"2014","unstructured":"Ali, M. K., Bullard, K. M., Gregg, E. W. & Del Rio, C. A cascade of care for diabetes in the United States: visualizing the gaps. Ann. Intern. Med. 161, 681\u2013689 (2014).","journal-title":"Ann. Intern. Med."},{"key":"742_CR39","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","volume":"311","author":"D Dabelea","year":"2014","unstructured":"Dabelea, D. et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 311, 1778\u20131786 (2014).","journal-title":"JAMA"},{"key":"742_CR40","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","volume":"376","author":"EJ Mayer-Davis","year":"2017","unstructured":"Mayer-Davis, E. J. et al. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N. Engl. J. Med. 376, 1419\u20131429 (2017).","journal-title":"N. Engl. J. Med."},{"key":"742_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"Tomic, D., Shaw, J. E. & Magliano, D. J. The burden and risks of emerging complications of diabetes mellitus. Nat. Rev. Endocrinol. 18, 525\u2013539 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"742_CR42","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","volume":"391","author":"EW Gregg","year":"2018","unstructured":"Gregg, E. W. et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 391, 2430\u20132440 (2018).","journal-title":"Lancet"},{"key":"742_CR43","doi-asserted-by":"publisher","first-page":"e15218","DOI":"10.1111\/dme.15218","volume":"41","author":"D Tomic","year":"2024","unstructured":"Tomic, D., Craig, M. E., Magliano, D. J. & Shaw, J. E. Reasons for hospitalisation in youth with type 1 diabetes, 2010-2019. Diabet. Med. 41, e15218 (2024).","journal-title":"Diabet. Med."},{"key":"742_CR44","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1073\/pnas.1920391117","volume":"117","author":"NK Mehta","year":"2020","unstructured":"Mehta, N. K., Abrams, L. R. & Myrskyl\u00e4, M. US life expectancy stalls due to cardiovascular disease, not drug deaths. Proc. Natl Acad. Sci. USA 117, 6998\u20137000 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"742_CR45","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","volume":"384","author":"M Fang","year":"2021","unstructured":"Fang, M., Wang, D., Coresh, J. & Selvin, E. Trends in diabetes treatment and control in U.S. adults, 1999-2018. N. Engl. J. Med. 384, 2219\u20132228 (2021).","journal-title":"N. Engl. J. Med."},{"key":"742_CR46","doi-asserted-by":"crossref","unstructured":"Geiss, L. S., et al. Resurgence of diabetes-related nontraumatic lower extremity amputation in the young and middle-aged adult U.S. population. Diabetes Care 42, 50\u201354 (2018).","DOI":"10.2337\/dc18-1380"},{"key":"742_CR47","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1001\/jama.2019.3471","volume":"321","author":"EW Gregg","year":"2019","unstructured":"Gregg, E. W., Hora, I. & Benoit, S. R. Resurgence in diabetes-related complications. Jama-J. Am. Med. Assoc. 321, 1867\u20131868 (2019).","journal-title":"Jama-J. Am. Med. Assoc."},{"key":"742_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110189","volume":"194","author":"M Quigley","year":"2022","unstructured":"Quigley, M. et al. Trends in diabetes-related foot disease hospitalizations and amputations in Australia, 2010 to 2019. Diabetes Res. Clin. Pract. 194, 110189 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"742_CR49","doi-asserted-by":"publisher","first-page":"789","DOI":"10.2337\/dc21-2268","volume":"45","author":"JI Morton","year":"2022","unstructured":"Morton, J. I., Lazzarini, P. A., Shaw, J. E. & Magliano, D. J. Trends in the incidence of hospitalization for major diabetes-related complications in people with type 1 and type 2 diabetes in Australia, 2010-2019. Diabetes Care 45, 789\u2013797 (2022).","journal-title":"Diabetes Care"},{"key":"742_CR50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00125-022-05845-9","volume":"66","author":"PA Lazzarini","year":"2023","unstructured":"Lazzarini, P. A. et al. Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century. Diabetologia 66, 267\u2013287 (2023).","journal-title":"Diabetologia"},{"key":"742_CR51","doi-asserted-by":"crossref","unstructured":"Maheswaran, R., et al. Time trends and geographical variation in major lower limb amputation related to peripheral arterial disease in England. BJS Open 8, zrad140 (2024).","DOI":"10.1093\/bjsopen\/zrad140"},{"key":"742_CR52","doi-asserted-by":"publisher","first-page":"e1002751","DOI":"10.1371\/journal.pmed.1002751","volume":"16","author":"J Manne-Goehler","year":"2019","unstructured":"Manne-Goehler, J. et al. Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 16, e1002751 (2019).","journal-title":"PLoS Med."},{"key":"742_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14940","volume":"40","author":"S Misra","year":"2023","unstructured":"Misra, S. et al. Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England. Diabetes Med. 40, e14940 (2023).","journal-title":"Diabetes Med."},{"key":"742_CR54","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1001\/jama.2021.5199","volume":"325","author":"SH Woolf","year":"2021","unstructured":"Woolf, S. H., Chapman, D. A., Sabo, R. T. & Zimmerman, E. B. Excess deaths from COVID-19 and other causes in the US, March 1, 2020, to January 2, 2021. Jama 325, 1786\u20131789 (2021).","journal-title":"Jama"},{"key":"742_CR55","doi-asserted-by":"publisher","first-page":"100420","DOI":"10.1016\/j.lanepe.2022.100420","volume":"19","author":"E McManus","year":"2022","unstructured":"McManus, E., Meacock, R., Parkinson, B. & Sutton, M. Population level impact of the NHS Diabetes Prevention Programme on incidence of type 2 diabetes in England: an observational study. Lancet Reg. Health Eur. 19, 100420 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"742_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100291","volume":"14","author":"JS Knudsen","year":"2022","unstructured":"Knudsen, J. S. et al. Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study. Lancet Reg. Health Eur. 14, 100291 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"742_CR57","doi-asserted-by":"publisher","first-page":"e679","DOI":"10.1542\/peds.2012-2583","volume":"131","author":"S Saydah","year":"2013","unstructured":"Saydah, S., Bullard, K. M., Imperatore, G., Geiss, L. & Gregg, E. W. Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality. Pediatrics 131, e679\u2013e686 (2013).","journal-title":"Pediatrics"},{"key":"742_CR58","doi-asserted-by":"crossref","unstructured":"Cheng, Y. J., et al. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care 36, 2690\u20132696 (2013).","DOI":"10.2337\/dc12-2074"},{"key":"742_CR59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2337\/dc20-2045","volume":"44","author":"JE Dibato","year":"2021","unstructured":"Dibato, J. E. et al. Association of cardiometabolic multimorbidity and depression with cardiovascular events in early-onset adult type 2 diabetes: a multiethnic study in the U.S. Diabetes Care 44, 231\u2013239 (2021).","journal-title":"Diabetes Care"},{"key":"742_CR60","doi-asserted-by":"crossref","unstructured":"Saydah, S. H., Siegel, K. R., Imperatore, G., Mercado, C. & Gregg, E. W. The cardiometabolic risk profile of young adults with diabetes in the U.S. Diabetes Care 42, 1895\u20131902 (2019).","DOI":"10.2337\/dc19-0707"},{"key":"742_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jdiacomp.2014.10.009","volume":"29","author":"JB Tryggestad","year":"2015","unstructured":"Tryggestad, J. B. & Willi, S. M. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J. Diabetes Complicat. 29, 307\u2013312 (2015).","journal-title":"J. Diabetes Complicat."},{"key":"742_CR62","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2017.0686","volume":"317","author":"D Dabelea","year":"2017","unstructured":"Dabelea, D. et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. Jama 317, 825\u2013835 (2017).","journal-title":"Jama"},{"key":"742_CR63","unstructured":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. Lancet Diabetes Endocrinol. 11, 731\u2013742 (2023)."},{"key":"742_CR64","doi-asserted-by":"publisher","first-page":"e072385","DOI":"10.1136\/bmj-2022-072385","volume":"379","author":"J Xie","year":"2022","unstructured":"Xie, J. et al. Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019. Bmj 379, e072385 (2022).","journal-title":"Bmj"},{"key":"742_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","volume":"9","author":"HR Murphy","year":"2021","unstructured":"Murphy, H. R. et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 9, 153\u2013164 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR66","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s00125-020-05199-0","volume":"63","author":"L Chen","year":"2020","unstructured":"Chen, L. et al. A systematic review of trends in all-cause mortality among people with diabetes. Diabetologia 63, 1718\u20131735 (2020).","journal-title":"Diabetologia"},{"key":"742_CR67","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.2337\/dc20-0886","volume":"43","author":"RM Anjana","year":"2020","unstructured":"Anjana, R. M. et al. Contrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries: cohort study data from 143,567 individuals in 21 countries in the PURE study. Diabetes Care 43, 3094\u20133101 (2020).","journal-title":"Diabetes Care"},{"key":"742_CR68","doi-asserted-by":"crossref","unstructured":"Liu, X., et al. Trends in the incidence and mortality of diabetes in China from 1990 to 2017: a joinpoint and age-period-cohort analysis. Int. J. Environ. Res. Public Health 16, 08 (2019).","DOI":"10.3390\/ijerph16010158"},{"key":"742_CR69","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/s41591-019-0644-7","volume":"25","author":"JJ Miranda","year":"2019","unstructured":"Miranda, J. J. et al. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat. Med. 25, 1667\u20131679 (2019).","journal-title":"Nat. Med."},{"key":"742_CR70","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1177\/193229681100500415","volume":"5","author":"M Deepa","year":"2011","unstructured":"Deepa, M., Anjana, R. M., Manjula, D., Narayan, K. M. & Mohan, V. Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai Urban Population Study. J. Diabetes Sci. Technol. 5, 918\u2013927 (2011).","journal-title":"J. Diabetes Sci. Technol."},{"key":"742_CR71","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.diabres.2014.01.005","volume":"104","author":"A Zabetian","year":"2014","unstructured":"Zabetian, A., Sanchez, I. M., Narayan, K. M., Hwang, C. K. & Ali, M. K. Global rural diabetes prevalence: a systematic review and meta-analysis covering 1990-2012. Diabetes Res. Clin. Pract. 104, 206\u2013213 (2014).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"742_CR72","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.diabres.2014.11.004","volume":"107","author":"R Shivashankar","year":"2015","unstructured":"Shivashankar, R. et al. Quality of diabetes care in low- and middle-income Asian and Middle Eastern countries (1993-2012): 20-year systematic review. Diabetes Res. Clin. Pract. 107, 203\u2013223 (2015).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"742_CR73","doi-asserted-by":"publisher","first-page":"260-+","DOI":"10.1038\/s41586-019-1171-x","volume":"569","author":"H Bixby","year":"2019","unstructured":"Bixby, H. et al. Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature 569, 260-+ (2019).","journal-title":"Nature"},{"key":"742_CR74","doi-asserted-by":"publisher","first-page":"e1003434","DOI":"10.1371\/journal.pmed.1003434","volume":"17","author":"D Flood","year":"2020","unstructured":"Flood, D. et al. Health system interventions for adults with type 2 diabetes in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 17, e1003434 (2020).","journal-title":"PLoS Med."},{"key":"742_CR75","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","volume":"401","author":"EW Gregg","year":"2023","unstructured":"Gregg, E. W. et al. Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact. Lancet 401, 1302\u20131312 (2023).","journal-title":"Lancet"},{"key":"742_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11892-018-1088-z","volume":"18","author":"MK Ali","year":"2018","unstructured":"Ali, M. K., Siegel, K. R., Laxy, M. & Gregg, E. W. Advancing measurement of diabetes at the population level. Curr. Diabetes Rep. 18, 108 (2018).","journal-title":"Curr. Diabetes Rep."},{"key":"742_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11892-019-1161-2","volume":"19","author":"R Jagannathan","year":"2019","unstructured":"Jagannathan, R., Patel, S. A., Ali, M. K. & Narayan, K. M. V. Global updates on cardiovascular disease mortality trends and attribution of traditional risk factors. Curr. Diabetes Rep. 19, 44 (2019).","journal-title":"Curr. Diabetes Rep."},{"key":"742_CR78","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa1605368","volume":"375","author":"J Alegre-Diaz","year":"2016","unstructured":"Alegre-Diaz, J. et al. Diabetes and cause-specific mortality in Mexico City. N. Engl. J. Med. 375, 1961\u20131971 (2016).","journal-title":"N. Engl. J. Med."},{"key":"742_CR79","unstructured":"Academy of Medical Scienes. Multimorbidity (MM): a priority for global health research. (2018)."},{"key":"742_CR80","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3399\/bjgp17X690857","volume":"67","author":"D Kernick","year":"2017","unstructured":"Kernick, D., Chew-Graham, C. A. & O\u2019Flynn, N. Clinical assessment and management of multimorbidity: NICE guideline. Br. J. Gen. Pract. 67, 235\u2013236 (2017).","journal-title":"Br. J. Gen. Pract."},{"key":"742_CR81","doi-asserted-by":"publisher","first-page":"l6964","DOI":"10.1136\/bmj.l6964","volume":"368","author":"CJM Whitty","year":"2020","unstructured":"Whitty, C. J. M. et al. Rising to the challenge of multimorbidity. Bmj 368, l6964 (2020).","journal-title":"Bmj"},{"key":"742_CR82","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","volume":"4","author":"JR Brownrigg","year":"2016","unstructured":"Brownrigg, J. R. et al. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol. 4, 588\u2013597 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"742_CR83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1046\/j.1464-5491.2000.00222.x","volume":"17","author":"CL Morgan","year":"2000","unstructured":"Morgan, C. L. et al. The prevalence of multiple diabetes-related complications. Diabetes Med. 17, 146\u2013151 (2000).","journal-title":"Diabetes Med."},{"key":"742_CR84","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa032782","volume":"352","author":"S Tesfaye","year":"2005","unstructured":"Tesfaye, S. et al. Vascular risk factors and diabetic neuropathy. N. Engl. J. Med. 352, 341\u2013350 (2005).","journal-title":"N. Engl. J. Med."},{"key":"742_CR85","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.2337\/dc10-0745","volume":"33","author":"AI Vinik","year":"2010","unstructured":"Vinik, A. I., Maser, R. E. & Ziegler, D. Neuropathy: the crystal ball for cardiovascular disease? Diabetes Care 33, 1688\u20131690 (2010).","journal-title":"Diabetes Care"},{"key":"742_CR86","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12872-020-01763-z","volume":"20","author":"XH Xu","year":"2020","unstructured":"Xu, X. H. et al. Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis. BMC Cardiovasc. Disord. 20, 478 (2020).","journal-title":"BMC Cardiovasc. Disord."},{"key":"742_CR87","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4093\/dmj.2015.39.6.498","volume":"39","author":"JS Yun","year":"2015","unstructured":"Yun, J. S. et al. Cardiovascular disease predicts severe hypoglycemia in patients with type 2 diabetes. Diabetes Metab. J. 39, 498\u2013506 (2015).","journal-title":"Diabetes Metab. J."},{"key":"742_CR88","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2337\/dc17-2138","volume":"41","author":"DJ Magliano","year":"2018","unstructured":"Magliano, D. J., Martin, V. J., Owen, A. J., Zomer, E. & Liew, D. The productivity burden of diabetes at a population level. Diabetes Care 41, 979\u2013984 (2018).","journal-title":"Diabetes Care"},{"key":"742_CR89","doi-asserted-by":"publisher","first-page":"e057017","DOI":"10.1136\/bmjopen-2021-057017","volume":"12","author":"IS Ho","year":"2022","unstructured":"Ho, I. S. et al. Variation in the estimated prevalence of multimorbidity: systematic review and meta-analysis of 193 international studies. BMJ Open 12, e057017 (2022).","journal-title":"BMJ Open"},{"key":"742_CR90","doi-asserted-by":"publisher","first-page":"m160","DOI":"10.1136\/bmj.m160","volume":"368","author":"LE Stirland","year":"2020","unstructured":"Stirland, L. E. et al. Measuring multimorbidity beyond counting diseases: systematic review of community and population studies and guide to index choice. Bmj 368, m160 (2020).","journal-title":"Bmj"},{"key":"742_CR91","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/JOE-20-0596","volume":"252","author":"E Ahlqvist","year":"2021","unstructured":"Ahlqvist, E., Prasad, R. B. & Groop, L. 100 years of insulin: towards improved precision and a new classification of diabetes mellitus. J. Endocrinol. 252, R59\u2013r70 (2021).","journal-title":"J. Endocrinol."},{"key":"742_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102703","volume":"74","author":"SJ Krauth","year":"2024","unstructured":"Krauth, S. J. et al. Association of latent class analysis-derived multimorbidity clusters with adverse health outcomes in patients with multiple long-term conditions: comparative results across three UK cohorts. EClinicalMedicine 74, 102703 (2024).","journal-title":"EClinicalMedicine"},{"key":"742_CR93","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/S2589-7500(22)00187-X","volume":"5","author":"V Kuan","year":"2023","unstructured":"Kuan, V. et al. Identifying and visualising multimorbidity and comorbidity patterns in patients in the English National Health Service: a population-based study. Lancet Digit Health 5, e16\u2013e27 (2023).","journal-title":"Lancet Digit Health"},{"key":"742_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5022","volume":"5","author":"AB Jensen","year":"2014","unstructured":"Jensen, A. B. et al. Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. Nat. Commun. 5, 4022 (2014).","journal-title":"Nat. Commun."},{"key":"742_CR95","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41591-023-02420-6","volume":"29","author":"C Langenberg","year":"2023","unstructured":"Langenberg, C., Hingorani, A. D. & Whitty, C. J. M. Biological and functional multimorbidity-from mechanisms to management. Nat. Med. 29, 1649\u20131657 (2023).","journal-title":"Nat. Med."},{"key":"742_CR96","doi-asserted-by":"publisher","first-page":"e102149","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan, C. et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PLoS One 9, e102149 (2014).","journal-title":"PLoS One"},{"key":"742_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett, K. et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380, 37\u201343 (2012).","journal-title":"Lancet"},{"key":"742_CR98","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2666-7568(21)00146-X","volume":"2","author":"A Head","year":"2021","unstructured":"Head, A. et al. Inequalities in incident and prevalent multimorbidity in England, 2004-19: a population-based, descriptive study. Lancet Healthy Longev. 2, e489\u2013e497 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"742_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1373-y","volume":"17","author":"M Nowakowska","year":"2019","unstructured":"Nowakowska, M. et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. 17, 145 (2019).","journal-title":"BMC Med."},{"key":"742_CR100","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41591-024-03123-2","volume":"30","author":"EW Gregg","year":"2024","unstructured":"Gregg, E. W. et al. The burden of diabetes-associated multiple long-term conditions on years of life spent and lost. Nat. Med. 30, 2830\u20132837 (2024).","journal-title":"Nat. Med."},{"key":"742_CR101","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ecl.2021.05.012","volume":"50","author":"M Cicek","year":"2021","unstructured":"Cicek, M., Buckley, J., Pearson-Stuttard, J. & Gregg, E. W. Characterizing multimorbidity from type 2 diabetes: insights from clustering approaches. Endocrinol. Metab. Clin. North Am. 50, 531\u2013558 (2021).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"742_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59336-1","volume":"10","author":"A Aguado","year":"2020","unstructured":"Aguado, A., Moratalla-Navarro, F., L\u00f3pez-Simarro, F. & Moreno, V. MorbiNet: multimorbidity networks in adult general population. Analysis of type 2 diabetes mellitus comorbidity. Sci. Rep. 10, 2416 (2020).","journal-title":"Sci. Rep."},{"key":"742_CR103","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.2337\/dci23-0035","volume":"46","author":"K Khunti","year":"2023","unstructured":"Khunti, K. et al. Diabetes and multiple long-term conditions: a review of our current global health challenge. Diabetes Care 46, 2092\u20132101 (2023).","journal-title":"Diabetes Care"},{"key":"742_CR104","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/S2468-2667(17)30074-9","volume":"2","author":"M Kivimaki","year":"2017","unstructured":"Kivimaki, M. et al. Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe. Lancet Public Health 2, e277\u2013e285 (2017).","journal-title":"Lancet Public Health"},{"key":"742_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01817-z","volume":"10","author":"SM Smith","year":"2021","unstructured":"Smith, S. M., Wallace, E., Clyne, B., Boland, F. & Fortin, M. Interventions for improving outcomes in patients with multimorbidity in primary care and community setting: a systematic review. Syst. Rev. 10, 271 (2021).","journal-title":"Syst. Rev."},{"key":"742_CR106","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/dom.15154","volume":"25","author":"KKF MedSci","year":"2023","unstructured":"Khunti K. F. et al. Weight change and risk of obesity-related complications: a retrospective population-based cohort study of a UK primary care database. Diabetes Obes. Metab. 25, 2669\u20132679 (2023).","journal-title":"Diabetes Obes. Metab."},{"key":"742_CR107","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/gerona\/glab342","volume":"77","author":"MA Espeland","year":"2022","unstructured":"Espeland, M. A. et al. Eight-year changes in multimorbidity and frailty in adults with type 2 diabetes mellitus: associations with cognitive and physical function and mortality. J. Gerontol. A Biol. Sci. Med Sci. 77, 1691\u20131698 (2022).","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"key":"742_CR108","unstructured":"Centers for Disease Control and Prevention. U.S. Diabetes Surveillance System and Diabetes Atlas. (2019)."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00742-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00742-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00742-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:25:37Z","timestamp":1739535937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00742-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["742"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00742-9","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.M. has received speaker Honoraria from Lilly and Sanofi, UK. K.K. has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Bayer, Novo Nordisk, Sanofi-Aventis, Servier, Lilly and Merck Sharp & Dohme, Boehringer Ingelheim, Oramed Pharmaceuticals, Pfizer, Roche, Daiichi-Sankyo, Applied Therapeutics, Embecta and Nestle Health Science. J.P.S. is a Partner at Lane Clark & Peacock LLP and Chair of the Royal Society for Public Health\u00a0and reports consultancy fees from Novo Nordisk outside of this work. J.V. was the National Clinical Director for Diabetes and Obesity at NHS England from April 2013 to September 2023 and currently is the National Clinical Lead for Multiple Long Term Conditions at NHS England.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}